The SBTi has Validated our Science-based targets
We are happy to announce that the SBTi has approved our near-term science-based emissions reduction targets for JRS Pharma OY. Throughout June, these targets will also be published on the SBTi website (Target Dashboard) to be viewed by all our customers and the general public.
The trajectory of the Corporate Carbon Footprint for the approved baseline year 2023 as well as the following years can be viewed here.
Sources of emissions * | t CO₂e (2023) | % (2023) |
|---|---|---|
Scope 1 | 1.982,31 | 12,48 |
1.1 Stationary combustion | 1.975,77 | 12,44 |
1.2 Mobile combustion | 6,54 | 0,04 |
Scope 2 | 3.797,55 | 23,90 |
2.1 Purchased electricity (market-based) | 1.237,54 | 7,79 |
2.2 Purchased heat | 2.560,01 | 16,11 |
Scope 3 | 10.107,89 | 63,62 |
3.1 Purchased goods and services | 2.126,07 | 13,38 |
3.2 Capital goods | 6.318,46 | 39,77 |
3.3 Fuel- and energy-related activities (not incl. in Scope 1 or Scope 2) | 1.022,46 | 6,44 |
3.4 Upstream transportation and distribution | 510,14 | 3,21 |
3.5 Waste generated in operations | 8,31 | 0,05 |
3.6 Business travel | 5,41 | 0,03 |
3.7 Employee commuting | 51,19 | 0,32 |
3.9 Downstream transportation and distribution | 0,00 | 0,00 |
3.12 End-of-life treatment of products | 65,84 | 0,41 |
Total result | 15.887,75 | 100% |
Electricity | t CO₂e (2023) |
|---|---|
Purchased electricity (location-based) | 3.069,28 |
* Only the actual and relevant emissions within the system boundary have been listed, as submitted to the SBTi for validation.
Strong Team for Sustainability Management
The newly established Sustainability Management team is focused on further advancing the JRS sustainability strategy. With the annual EcoVadis and CDP ratings, the team is taking important first steps toward transparent and credible sustainability performance assessment.
